Active Clinical Trials

All Clinical Trials

Below is a list of all clinical trials, conducted by several of our specialty service lines. You may filter the list of trials by clicking the "Department" dropdown menu and selecting the area that you want to view or that pertains to you.

Clicking "Learn More" may either take you to more information about our departments that conduct the research, or to the official clinicaltrials.gov page for more information about the trial.

Adult Oncology Trials Pediatric Oncology Trials

Breast Cancer

OptimICE-pCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy

Study # A012103 Date Opened: 06/14/2023 Principal Investigator: Qiwei Gai

Learn More

Hematologic Cancer

A Phase 3, Two-Stage, Randomized, Multicenter, Open-label Study Comparing Mezigdomide(CC-92480), Bortezomib, and Dexamethasone (MeziVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM)

Study # NCT05519085 Date Opened: 09/20/2022 Principal Investigator: Qiwei Gai

Learn More

Supportive Cancers

Blinded Reference Set for Multicancer Early Detection Blood Tests

Study # A212102 Date Opened: 08/30/2022 (All Centers) Principal Investigator: Qiwei Gai

Learn More

Active Clinical Trials

All Clinical Trials

OptimICE-pCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy

A Phase 3, Two-Stage, Randomized, Multicenter, Open-label Study Comparing Mezigdomide(CC-92480), Bortezomib, and Dexamethasone (MeziVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM)

Blinded Reference Set for Multicancer Early Detection Blood Tests

Reach Out to Our Researchers